| 1 |
Circulars dated 27 Oct 2021 regarding |
2021-Oct-27 |
|
901 KB |
| 2 |
Prior approval for Global Tender Enquiry under rule 161(Vi) of General Financial Rules (GFRs) |
2021-Oct-14 |
|
1338 KB |
| 3 |
Office Order regarding the Leaves(s) in respect of the officers of CDSCO |
2021-Oct-12 |
|
432 KB |
| 4 |
Office order regarding leaves granted to Officers of CDSCO |
2021-Aug-19 |
|
930 KB |
| 5 |
Circular regarding Azadi Ka Amrit Mahotsav |
2021-Aug-12 |
|
2039 KB |
| 6 |
Circular regarding attending office during Parliament Session |
2021-Aug-03 |
|
1880 KB |
| 7 |
Data for Income Tax Calculation for the Financial Year 2021-22 |
2021-Aug-02 |
|
3990 KB |
| 8 |
Clarification if change in a) Polymorphs/crystalline/amorphous/solvates/hydrate etc (b) salt and (c) Derivative/analogue/ester etc of already approved active substance to be considered as new drug if main active moiety (Active Pharmaceutical Ingredient-API) is same? |
2021-Jul-23 |
|
131 KB |
| 9 |
Consolidated Instructions for Global Tender Enquiry (GTE) under Rule 161(iv) of General Financial Rules (GFRs), 2017 |
2021-Jul-07 |
|
3372 KB |
| 10 |
Circular regarding attending office regularly dated 07.07.2021 |
2021-Jul-07 |
|
602 KB |
